SCHIZOPHRENIFORM DISORDERS

This study tested whether delivering mental health services by video (telehealth) helps young people with psychotic disorders stay engaged in care and avoid hospital stays better than standard in-person clinic visits. 74 people aged 16-35 with early psychosis took part. The goal …

This study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 adults took either the drug or a placebo, and researchers measured changes in agitation levels and safety. The …

This study looked at what happens when people with schizophrenia or bipolar disorder take Igalmi repeatedly for agitation over 7 days, and then stop. Researchers wanted to see if the drug becomes less effective (tolerance) or causes withdrawal symptoms. 29 adults participated in …

This study tested whether sending text message reminders helps young people (ages 14-35) with psychosis attend their first appointment at an early psychosis program after being seen in the emergency room. Researchers enrolled 186 participants and tracked whether they showed up fo…

This study looked at how young adults aged 18-30 with early psychosis process information from their surroundings, compared to those without a psychiatric diagnosis. Participants completed computer-based tasks and cognitive training to measure changes in attention and decision-ma…

This study looked at whether a program called NAVIGATE helps youth (ages 14-35) having their first episode of psychosis get better coordinated care. Researchers worked with 100 participants across Ontario to see if the program reduces hospital stays and ER visits. The goal was to…

This study looked at whether family members or caregivers can help measure agitation in people with bipolar disorder or schizophrenia. 33 adults took a single dose of an experimental medicine, and researchers compared ratings from doctors, patients, and their family members. The …